Intravascular ultrasound data and results of serum biochemical indices at the time of stenting and after six months in patients with coronary artery disease

Pteridines

Volumn 17, Issue 3, 2006, Pages 95-99

  Rudzite, Vera ^a   Jurika, Edite ^a   Erglis, Andrejs ^b   Trusinskis, Karlis ^b   Jegere, Sanda ^b   Fuchs, Dietmar ^c  

^a UNIVERSITY OF LATVIA   (Latvia)

^b PAULS STRADINS CLINICAL UNIVERSITY HOSPITAL   (Latvia)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

C reactive protein; Homocysteine; Intrvascular ultrasound; Kynurenine; Lipids; Neopterin; Pyridoxal 5 phosphate

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM ANTAGONIST; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; KYNURENINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NEOPTERIN; NITRITE; PHOSPHOLIPID; PYRIDOXAL 5 PHOSPHATE; SATURATED FATTY ACID; TRIACYLGLYCEROL; UNSATURATED FATTY ACID; ZOKOR;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CELL METABOLISM; CHEMICAL ANALYSIS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; DRUG EFFECT; FEMALE; FOLLOW UP; HUMAN; INTRAVASCULAR ULTRASOUND; LIPID METABOLISM; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 33750935461     PISSN: 09334807     EISSN: 21954720     Source Type: Journal    
DOI: 10.1515/pteridines.2006.17.3.95     Document Type: Article

References (23)

1. MC Namara JJ, Molot MA, Stumpe JF, Cutting RT. Coronary artery disease in combat causalities in Vietnam. J Am Med Assoc 1971; 216: 1185-1187.
2. Tuzcu EM, Kapadia SR, Tutar E et al. High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults: evidence from intravascular ultrasound. Circulation 2001; 103: 2705-2710.
3. Nissen SE. Who is at risk for atherosclerotic disease? Lessons from intravascular ultrasound. Am J Med 2002; 112: 27S-33S.
4. Gotto A, Pownal H. Manual of Lipid Disorders. Philadelphia: Lippincot, Williams and Wilkins 2003.
5. Fuchs D, Weiss G, Reibnegger G, Wachter H. The Role of Neopterin as a Monitor of Cellular Immune Activation in Transplantation, Inflammation, Infections and Malignant Diseases. Berlin: Walter de Gruyter 1992.
6. Du Clos TW. Function of C-reactive protein. Ann Med 2000; 32: 274-278.
7. Rudzite V, Jurika E, Schroecksnadel K, et al. Usefulness of neopterin, C-reactive protein, homocysteine, pyridoxal-5-phosphate and phospholipid determination in coronary artery disease. Pteridines 2005; 16: 15-21.
8. Ueland PM. Plasma homocysteine and cardiovascular disease. In: Francis R (ed.) Atherosclerotic Cardiovascular Disease and Endothelial Function. New York: Marcel Dekker 1990; 183-238.
9. Tsai IC, Perella MA, Yoshizumi M. Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc Nat Acad Sci USA 1994; 91: 6373-6396.
10. Rudzite V, Lacis J, Tiruma B. Diagnostic method of ischémie heart disease. Invention of USSR and abroad (MKU-61). 1984; 13: 4-4.
11. Rudzite V, Sileniece G, Jirgensons J, et al. The significance of increased kynurenine level in blood to the development of cardiovascular pathology. Acta Medica Baltica 1994; 1: 4-19.
12. Rudzite V, Jurika E, Kalnins U, Erglis A, Trusinskis K, Jegere S. Changes in lipid metabolism in patient with coronary heart disease. Proc Latvian Acad Sci 2003; 57: 22-26.
13. Serfontein J, Ubbink JB, De Viller S, Rapley CH, Becker JP. Plasma pyridoxal-5-phosphate level as risk index for coronary artery disease. Atherosclerosis 1985; 55: 357-361.
14. Erglis A, Kalninš U, Saltups A, et al. Simple barotrauma reduction during coronary stenting: Effect on six-month neointimal proliferation. Riga - noncompliant balloon study. Proc Latvian Acad Sci 2004; 58; 120-126.
15. Widner B, Werner ER, Schennach H, Wachter H, Fuchs D. Simultaneous measurement of serum tryptophan and kynurenine by HPLC. Clin Chem 1997; 43: 2424-2426.
16. Folch J, Lees M, Stanley GM. A simple method for isolation and purification of total lipids from animal tissues. J Biol Chem 1957; 226: 497-507.
17. Homolka I. Bestimmung des anorganischen Phosphors nach Urbach-Raabe (modifiziert). In: Chemische Diagnostik im Kinders alter mit Bevorzugung des mikrometrischen Blutanalysen. Berlin: Verlag Volk und Gesundheit 1961; 354-355.
18. Kates M. Technique of Lipidology. Moscow: Mir 1978; 201-203. (Russ.)
19. De Jaegere P, Mudra H, Figulla H, et al. Intravascular ultrsound-guided optimised stent deployment. Immediate and 6 month clinical and angiographic results from the multicenter ultrasound stenting in coronaries study (MUSIC Study). Eur Heart J 1998; 19: 1214-1223.
20. Fitzerald PJ, Oshima A, Hayase M, et al. Final results of the can routine ultrasound influence stent expansion (CRUISE) study. Circulation 2000; 102: 523-530.
21. Oemrawisingh PV, Mirtz GS, Schalij MJ, Zwinderman AH, Jekema JV, van der Wall EE. Intravascular ultrasound guidance improves artery stenosis: final results of a randomised comparison with angiographic guidance (TULIP study). Circulation 2003; 107: 62-67.
22. Rudzite V, Jurika E, Fuchs D, Kalnins U, Erglis A, Trusinskis K. Inflammation, homocysteine, pyridoxal-5-phosphate and lipids in patients with coronary artery disease before and six month after coronary angioplasty followed by stent implantation. Pteridines 2005; 16: 190-194.
23. Frick B, Schroecksnadel K, Neurauter G, Leblhuber F, Fuchs D. Increasing production of homocysteine and neopterin and degradation of tryptophan with older age. Clin Biochem 2004; 37: 684-687.